English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

To the Editor: Primary biliary cirrhosis (PBC) is a chronic cholestatic autoimmune liver disease of unknown etiology, associated with the presence of antimitochondrial antibodies in 95% of patients1–6. Prevalence of this condition is estimated at between 20 and 240 cases per million population, the most frequent symptoms being fatigue, jaundice, and pruritis. Arthritis is reported in 4%–42% of patients with PBC in several series1–3. Some patients develop a symmetrical erosive small-joint arthritis, often in association with a positive rheumatoid factor (RF), that is indistinguishable from rheumatoid arthritis (RA). There is an increased incidence of RA, Sjogren’s syndrome, Raynaud’s phenomenon, and hypothyroidism in patients with PBC7. Up to 31% of patients, however, develop an asymmetric, nondeforming arthritis that seems unique to PBC7. However, there have been reports of PBC patients developing a deforming and/or erosive arthritis3,4, … Address correspondence to Dr. Smith; E-mail: malcolm.smith{at}health.sa.gov.au

Inflammatory Arthritis in a Patient with Primary Biliary Cirrhosis: B Cell Mediated Synovitis